Biotech product launch trends for emerging biopharma companies US EU
Biotech product launch activity by emerging biopharma companies is rising in the U.S., while European entries remain limited due to pricing and market complexity. Many first-time biotech product launch programs extend to Europe using solo or out-licensing models, with Switzerland emerging as a preferred regional base. For more info: https://www.zs.com/insights/us-novel-first-launches-implications-emerging-biopharma
Biotech product launch activity by emerging biopharma companies is rising in the U.S., while European entries remain limited due to pricing and market complexity. Many first-time biotech product launch programs extend to Europe using solo or out-licensing models, with Switzerland emerging as a preferred regional base. For more info: https://www.zs.com/insights/us-novel-first-launches-implications-emerging-biopharma
Biotech product launch trends for emerging biopharma companies US EU
Biotech product launch activity by emerging biopharma companies is rising in the U.S., while European entries remain limited due to pricing and market complexity. Many first-time biotech product launch programs extend to Europe using solo or out-licensing models, with Switzerland emerging as a preferred regional base. For more info: https://www.zs.com/insights/us-novel-first-launches-implications-emerging-biopharma
0 Comentários
0 Compartilhamentos
34 Visualizações
0 Anterior
English
Arabic
French
Spanish
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek